PTH(1–34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial | Zendy

Andrea Palermo | Zendy; Giuseppe Mangiameli | Zendy; Gaia Tabacco | Zendy; Filippo Longo | Zendy; Claudio Pedone | Zendy; Silvia Briganti | Zendy; Daria Maggi | Zendy; Fabio Vescini | Zendy; Anda Mihaela Naciu | Zendy; Angelo Lauria Pantano | Zendy; Nicola Napoli | Zendy; Silvia Angeletti | Zendy; Paolo Pozzilli | Zendy; Pierfilippo Crucitti | Zendy; Silvia Manfrini | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

PTH(1–34) for the Primary Prevention of Postthyroidectomy Hypocalcemia: The THYPOS Trial

Author(s) -

Andrea Palermo,

Giuseppe Mangiameli,

Gaia Tabacco,

Filippo Longo,

Claudio Pedone,

Silvia Briganti,

Daria Maggi,

Fabio Vescini,

Anda Mihaela Naciu,

Angelo Lauria Pantano,

Nicola Napoli,

Silvia Angeletti,

Paolo Pozzilli,

Pierfilippo Crucitti,

Silvia Manfrini

Publication year - 2016

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2016-2530

Subject(s) - medicine , interquartile range , teriparatide , randomized controlled trial , confidence interval , thyroidectomy , relative risk , surgery , incidence (geometry) , parathyroid hormone , vitamin d and neurology , parathyroidectomy , calcium , thyroid , physics , optics

There are no studies evaluating teriparatide for prevention of post-thyroidectomy hypocalcemia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research